Unit of Endocrinology of Azienda Ospedaliera-Universitaria di Modena
Modena, Italy
Location status: Recruiting
NCT Number: NCT06178887
Considering the high prevalence of cardiovascular disease in Turner syndrome patients, noninvasive cardiac imaging is crucial for diagnosis and follow-up. From the review of the literature, it was evident that the imaging techniques used involved the evaluation of only the thoracic findings, in particular the heart and the thoracic aorta, while no data are currently available on the distal abdominal aorta or iliac arteries, since ultrasound and MRI are interrupted at the diaphragmatic level.
Interested in participating?
Request Info18 year and older
Female
Observational
Modena, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
cardiac angioMR
Time frame: 5 years
description of the main cardiovascular anomalies found by MRI at the thoracic and abdominal level anomalies in terms of supernumeray arteries and/or veins and measurement of length and diameters of main vascular tracts (e.g. ascending, descending aorta, aortic arch, renal arteries...) or vascular congenital abnormalities
Contact information is provided by the study sponsor or research team.
Azienda Ospedaliero-Universitaria di Modena
Other
Role of Cardiac Magnetic Resonance Angiography (1.5-T) in the Diagnosis of Cardiac and Thoraco-abdominal Vascular Tree Anomalies in Adult Patients with Turner Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04948658
Brain Diseases, Brain Diseases, Metabolic
Bethesda, Maryland, United States
View Trial DetailsNCT07221851
Bone Diseases, Bone Diseases, Developmental
Palo Alto, California, United States
View Trial DetailsNCT02417740
Cardiovascular Abnormalities, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07614152
Cardiovascular Abnormalities, Cardiovascular Diseases
Anyang, China
View Trial Details